Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Toro-Tobon

Showing results (1-10 of 38) with videos related to

Pageof 4
Sort By:
The Journal of Clinical Endocrinology and Metabolism|February 16, 2026
The Prediction Paradox: AI, Genetics, and Occult Metastasis in Thyroid CancerDavid Toro-Tobon
The Clinical Teacher|September 6, 2022
Awareness, perceptions, and characteristics of internal medicine residents as role modelsDavid Toro-Tobon, Sarah Thornton
The Journal of Clinical Endocrinology and Metabolism|January 14, 2026
Graves' Disease: A New Era of Pathophysiology-Guided TherapeuticsMarius N Stan, David Toro-Tobon
Annals of Internal Medicine|June 2, 2025
In untreated Graves disease, adding methotrexate to methimazole increased euthyroidism-related treatment discontinuation at 18 moDavid Toro-Tobon, Aoife M Egan,
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|June 14, 2024
Controversies in the Management of Intermediate-Risk Differentiated Thyroid CancerDavid Toro-Tobon, Juan P Brito
European Journal of Endocrinology|August 12, 2025
The evolving landscape of thyroid eye disease: present and futureDavid Toro-Tobon, Marius N Stan
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|April 5, 2026
From Uncertainty to Precision: AI-Enhanced Molecular Diagnostics for Thyroid NodulesAnoopa Mathew, David Toro-Tobon, Maria Papaleontiou
Women'S Health (London, England)|May 2, 2023
Cardiovascular benefits and risks associated with calcium, vitamin D, and antiresorptive therapy in the management of skeletal fragilityAnnop Kittithaworn, David Toro-Tobon, Jad G Sfeir
Thyroid : Official Journal of the American Thyroid Association|January 8, 2025
Thyroid Cancer Risk with GLP-1 Receptor Agonists: Evidence, Knowledge Gaps, and the Path ForwardDavid Toro-Tobon, Naykky Singh Ospina, Juan P Brito
JAMA Oncology|January 2, 2026
Thyroid Nodule Molecular Classifiers-Reclaiming Deliberation in an Era of AutomationJuan P Brito, David Toro-Tobon, Victor M Montori
Pageof 4

Showing results (1-10 of 38) with videos related to

Sort By:
Pageof 4
The Journal of Clinical Endocrinology and Metabolism|February 16, 2026
The Prediction Paradox: AI, Genetics, and Occult Metastasis in Thyroid CancerDavid Toro-Tobon
The Clinical Teacher|September 6, 2022
Awareness, perceptions, and characteristics of internal medicine residents as role modelsDavid Toro-Tobon, Sarah Thornton
The Journal of Clinical Endocrinology and Metabolism|January 14, 2026
Graves' Disease: A New Era of Pathophysiology-Guided TherapeuticsMarius N Stan, David Toro-Tobon
Annals of Internal Medicine|June 2, 2025
In untreated Graves disease, adding methotrexate to methimazole increased euthyroidism-related treatment discontinuation at 18 moDavid Toro-Tobon, Aoife M Egan,
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|June 14, 2024
Controversies in the Management of Intermediate-Risk Differentiated Thyroid CancerDavid Toro-Tobon, Juan P Brito
European Journal of Endocrinology|August 12, 2025
The evolving landscape of thyroid eye disease: present and futureDavid Toro-Tobon, Marius N Stan
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|April 5, 2026
From Uncertainty to Precision: AI-Enhanced Molecular Diagnostics for Thyroid NodulesAnoopa Mathew, David Toro-Tobon, Maria Papaleontiou
Women'S Health (London, England)|May 2, 2023
Cardiovascular benefits and risks associated with calcium, vitamin D, and antiresorptive therapy in the management of skeletal fragilityAnnop Kittithaworn, David Toro-Tobon, Jad G Sfeir
Thyroid : Official Journal of the American Thyroid Association|January 8, 2025
Thyroid Cancer Risk with GLP-1 Receptor Agonists: Evidence, Knowledge Gaps, and the Path ForwardDavid Toro-Tobon, Naykky Singh Ospina, Juan P Brito
JAMA Oncology|January 2, 2026
Thyroid Nodule Molecular Classifiers-Reclaiming Deliberation in an Era of AutomationJuan P Brito, David Toro-Tobon, Victor M Montori
Pageof 4